
Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer
Esperion, announced that John Harlow will join the company as Chief Commercial Officer, effective November 17, 2025. In his new role, Mr. Harlow will become

Esperion, announced that John Harlow will join the company as Chief Commercial Officer, effective November 17, 2025. In his new role, Mr. Harlow will become

Esperion, which trades on as ESPR, has welcomed the recent update from the European Society of Cardiology and the European Atherosclerosis Society. The new guidelines